Borderline ovarian tumours: management in the era of fertility-sparing surgery

Borderline ovarian tumours (BOTs) are ovarian neoplasms characterised by epithelial proliferation, variable nuclear atypia and no evidence of destructive stromal invasion. BOTs account for approximately 15% of all epithelial ovarian cancers. Due to the fact that the majority of BOTs occur in women u...

Descripción completa

Detalles Bibliográficos
Autores principales: Maramai, Mattia, Barra, Fabio, Menada, Mario Valenzano, Stigliani, Sara, Moioli, Melita, Costantini, Sergio, Ferrero, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221127/
https://www.ncbi.nlm.nih.gov/pubmed/32419843
http://dx.doi.org/10.3332/ecancer.2020.1031
_version_ 1783533303857414144
author Maramai, Mattia
Barra, Fabio
Menada, Mario Valenzano
Stigliani, Sara
Moioli, Melita
Costantini, Sergio
Ferrero, Simone
author_facet Maramai, Mattia
Barra, Fabio
Menada, Mario Valenzano
Stigliani, Sara
Moioli, Melita
Costantini, Sergio
Ferrero, Simone
author_sort Maramai, Mattia
collection PubMed
description Borderline ovarian tumours (BOTs) are ovarian neoplasms characterised by epithelial proliferation, variable nuclear atypia and no evidence of destructive stromal invasion. BOTs account for approximately 15% of all epithelial ovarian cancers. Due to the fact that the majority of BOTs occur in women under 40 years of age, their surgical management often has to consider fertility-sparing approaches. The aim of this mini-review is to discuss the state of the art of fertility-sparing surgery for BOTs with a specific focus on the extent of surgery, post-operative management and fertility.
format Online
Article
Text
id pubmed-7221127
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-72211272020-05-15 Borderline ovarian tumours: management in the era of fertility-sparing surgery Maramai, Mattia Barra, Fabio Menada, Mario Valenzano Stigliani, Sara Moioli, Melita Costantini, Sergio Ferrero, Simone Ecancermedicalscience Review Borderline ovarian tumours (BOTs) are ovarian neoplasms characterised by epithelial proliferation, variable nuclear atypia and no evidence of destructive stromal invasion. BOTs account for approximately 15% of all epithelial ovarian cancers. Due to the fact that the majority of BOTs occur in women under 40 years of age, their surgical management often has to consider fertility-sparing approaches. The aim of this mini-review is to discuss the state of the art of fertility-sparing surgery for BOTs with a specific focus on the extent of surgery, post-operative management and fertility. Cancer Intelligence 2020-05-06 /pmc/articles/PMC7221127/ /pubmed/32419843 http://dx.doi.org/10.3332/ecancer.2020.1031 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Maramai, Mattia
Barra, Fabio
Menada, Mario Valenzano
Stigliani, Sara
Moioli, Melita
Costantini, Sergio
Ferrero, Simone
Borderline ovarian tumours: management in the era of fertility-sparing surgery
title Borderline ovarian tumours: management in the era of fertility-sparing surgery
title_full Borderline ovarian tumours: management in the era of fertility-sparing surgery
title_fullStr Borderline ovarian tumours: management in the era of fertility-sparing surgery
title_full_unstemmed Borderline ovarian tumours: management in the era of fertility-sparing surgery
title_short Borderline ovarian tumours: management in the era of fertility-sparing surgery
title_sort borderline ovarian tumours: management in the era of fertility-sparing surgery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221127/
https://www.ncbi.nlm.nih.gov/pubmed/32419843
http://dx.doi.org/10.3332/ecancer.2020.1031
work_keys_str_mv AT maramaimattia borderlineovariantumoursmanagementintheeraoffertilitysparingsurgery
AT barrafabio borderlineovariantumoursmanagementintheeraoffertilitysparingsurgery
AT menadamariovalenzano borderlineovariantumoursmanagementintheeraoffertilitysparingsurgery
AT stiglianisara borderlineovariantumoursmanagementintheeraoffertilitysparingsurgery
AT moiolimelita borderlineovariantumoursmanagementintheeraoffertilitysparingsurgery
AT costantinisergio borderlineovariantumoursmanagementintheeraoffertilitysparingsurgery
AT ferrerosimone borderlineovariantumoursmanagementintheeraoffertilitysparingsurgery

Ejemplares similares